Tolerability of different oral iron supplements: a systematic review

References

• Zimmermann MB, Hurrell RF. Nutritional iron deficiency. Lancet 2007;370:511-20
   Google Scholar
• WHO Global Database on Anaemia. Worldwide prevalence of anaemia 1993-2005. Available at: http://whqlibdoc.who.int/publications/2008/9789241596657_eng.pdf
   Google Scholar
• World Health Organization. Iron Deficiency Anaemia. Assessment, Prevention, and Control. A guide for programme managers. Geneva, World Health Organization, 2001 (WHO/NHD/01.3). Available at: http://www.who.int/nutrition/publications/micronutrients/anaemia_iron_deficiency/WHO_NHD_01.3/en/index.html
   Google Scholar
• World Health Organization. The World Health Report 2002: Reducing risks, promoting healthy life. Geneva: World Health Organization, 2002
   Google Scholar
• Centers for Disease Control and Prevention. Recommendations to prevent and control iron deficiency in the United States. MMWR 1998;47:23-25
   Google Scholar
• WHO Model Formulary 2008 (based on WHO Model List of Essential Medicines). Available at: http://www.who.int/selection_medicines/list/en/index.html
   Google Scholar
• WHO. Model List of Essential Medicines. 16th edn. Update March 2010. Geneva, Switzerland. Available at: http://www.who.int/medicines/publications/essentialmedicines/en/index.html
   Google Scholar
• Dietzfelbinger H, Kaboth W. Investigations of the bioavailability of iron from bi- and trivalent iron salts. Med Klin 1977;72:654-9
   PubMed Web of Science ®Google Scholar
• Dietzfelbinger H, Kaboth W. Comparison of bio-availability, antianaemic efficacy, tolerance and drug costs in oral iron(II) and iron(III) preparations. Med Klin 1979;74:1818-24
   PubMed Web of Science ®Google Scholar
• Dietzfelbinger H. Bioavailability of bi- and trivalent oral iron preparations. Arzneimittelforschung 1987;37:107-112
   PubMed Web of Science ®Google Scholar
• Heinrich HC. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes. Arzneimittelforschung 1975;25:420-6
   PubMed Web of Science ®Google Scholar
• Jacobs P, Fransman D, Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulfate in iron-deficient blood donors. J Clin Apher 1993;8:89-95
   PubMedGoogle Scholar
• Kaltwasser JP, Werner E, Niechzial M. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations. Arzneimittelforschung 1987;37:122-9
   PubMed Web of Science ®Google Scholar
• Nielsen P, Gabbe EE, Fischer R, et al. Bioavailability of iron from oral ferric polymaltose in humans. Arzneimittelforschung 1994;44:743-8
   PubMed Web of Science ®Google Scholar
• Pennell MD, Davies MI, Rasper J, Motzok I. Biological availability of iron supplements for rats, chicks and humans. J Nutr 1976;106:265-74
   PubMed Web of Science ®Google Scholar
• Todd T, Caroe T. Newly diagnosed iron deficiency anaemia in a premenopausal woman. BMJ 2007;334:259
   PubMed Web of Science ®Google Scholar
• Harju E. Clinical pharmacokinetics of iron preparations. Clin Pharmacokinet 1989;17:69-89
   PubMed Web of Science ®Google Scholar
• McDiarmid T, Johnson ED. Clinical inquiries. Are any oral iron formulations better tolerated than ferrous sulfate? J Fam Pract 2002;51:576
   PubMedGoogle Scholar
• Beutler E, Hoffbrand AV, Cook JD. Iron deficiency and overload. Hematology Am Soc Hematol Educ Program 2003;1:40-61
   Google Scholar
• Aronoff GR. Safety of intravenous iron in clinical practice: implications for anemia management protocols. J Am Soc Nephrol 2004;15(Suppl 2):S99 -106
   Google Scholar
• Eckstein RP, Symons P. Iron tablets cause histopathologically distinctive lesions in mucosal biopsies of the stomach and esophagus. Pathology 1996;28:142-5
   PubMed Web of Science ®Google Scholar
• Boyce HW. Drug-induced esophageal damage: diseases of medical progress. Gastrointest Endosc 1998;47:547-50
   PubMed Web of Science ®Google Scholar
• Abraham SC, Yardley JH, Wu TT. Erosive injury to the upper gastrointestinal tract in patients receiving iron medication: an underrecognized entity. Am J Surg Pathol 1999;23:1241-7
   PubMed Web of Science ®Google Scholar
• Ji H, Yardley JH. Iron medication-associated gastric mucosal injury. Arch Pathol Lab Med 2004;128:821-2
   PubMed Web of Science ®Google Scholar
• Alleyne M, Horne MK, Miller JL. Individualized treatment for iron-deficiency anemia in adults. Am J Med 2008;121:943-8
   PubMed Web of Science ®Google Scholar
• Hansen CM. Oral iron supplements. Am Pharm 1994;NS34:66-71
   PubMedGoogle Scholar
• Reveiz L, Gyte GM, Cuervo LG. Treatments for iron-deficiency anaemia in pregnancy. Cochrane Database Syst Rev 2007 Apr 18;(2):CD003094
   Google Scholar
• Peña-Rosas JP, Viteri FE. Effects and safety of preventive oral iron or iron+folic acid supplementation for women during pregnancy. Cochrane Database Syst Rev 2009 Oct 7;(4):CD004736
   Google Scholar
• Remacha AF, Canals C. La anemia en la gestación. Haematologica 2006;91:189-195
   Google Scholar
• Schümann K, Ettle T, Szegner B, et al. On risks and benefits of iron supplementation recommendations for iron intake revisited. J Trace Elem Med Biol 2007;21:147-68
   PubMed Web of Science ®Google Scholar
• Souza AI, Batista Filho M, Bresani CC, et al. Adherence and side effects of three ferrous sulfate treatment regimens on anemic pregnant women in clinical trials. Cad Saude Publica 2009;25:1225-33
   PubMed Web of Science ®Google Scholar
• Tessema J, Jefferds ME, Cogswell M, Carlton E. Motivators and barriers to prenatal supplement use among minority women in the United States. J Am Diet Assoc 2009;109:102-8
   PubMed Web of Science ®Google Scholar
• Gilmartin C. Pharmacist's role in managing anemia in patients with chronic kidney disease: potential clinical and economic benefits. Am J Health Syst Pharm 2007;64:S15-22
   Google Scholar
• Köpcke W, Sauerland MC. Meta-analysis of efficacy and tolerability data on iron protein succinylate in patients with iron deficiency anemia of different severity. Arzneimittelforschung 1995;45:1211-16
   PubMed Web of Science ®Google Scholar
• Blanc B, Magnenat P, Delaloyle B. Factors affecting the bonding of iron and their influence on absorption and metabolism. In: Hallberg HG, Vannoti A, eds. Iron deficiency. Pathogenesis – Clinical Aspects – Therapy. London, New York: Academic Press, 1970:135-50
   Google Scholar
• Mitchell ABS. Oral iron tolerance. Postgrad Med J 1974;50:702-6
   PubMed Web of Science ®Google Scholar
• Hallberg L, Björn-Rasmussen E, Ekenved G, et al. Absorption from iron tablets given with different types of meals. Scand J Haematol. 1978;21:215-24
   PubMedGoogle Scholar
• Schindler VH, Bielesz G. Treatment of iron deficiency with orally administered delayed-action ferrous sulfate and mucoproteose. Wien Med Wochenschr 1975;125:173-6
   PubMedGoogle Scholar
• Hallberg L, Ryttinger L, Sölvell L. Side-effects of oral iron therapy. Acta Med Scand Suppl 1966;459:3-10
   PubMedGoogle Scholar
• Symonds EM, Radden HS, Cellier KM. Controlled-release iron therapy in pregnancy. Aust N Z J Obstet Gynaecol 1969;9:21-5
   PubMed Web of Science ®Google Scholar
• Elwood PC, Williams G. A comparative trial of slow-release and conventional iron preparations. Practitioner 1970;204:812-5
   PubMedGoogle Scholar
• Aronstam A, Aston DL. A comparative trial of a controlled-release iron tablet preparation ('Ferrocontin' Continus) and ferrous fumarate tablets. Pharmatherapeutica 1982;3:263-7
   PubMedGoogle Scholar
• Milman N, Byg KE, Bergholt T, et al. Side effects of oral iron prophylaxis in pregnancy--myth or reality? Acta Haematol 2006;115:53-7
   PubMed Web of Science ®Google Scholar
• Metzger KH. A new oral iron preparation with a new concept. Fortschr Med 1978;96:779-82
   PubMedGoogle Scholar
• IMS Health Research. Medical Prescriptions Study. Analysis by form and posology for Spain, 2011:Jan-March:64-5
   Google Scholar
• Collet D. Modelling Binary Data. London: Chapman and Hall, 2003
   Google Scholar
• Chappuis F, Rijal S, Soto A, et al. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ 2006;333:723
   PubMed Web of Science ®Google Scholar
• McCullagh P, Nelder JA. Generalized Linear Models, 2nd edn. London: Chapman & Hall, 1989:124-8
   Google Scholar
• R Development Core Team. R: A language and environment for statistical computing. In: R foundation for statistical computing, Vienna, Austria, 2004. At www.R-project.org (accessed February 2011)
   Google Scholar
• Kerr DN, Davidson S. The prophylaxis of iron-deficiency anaemia in pregnancy. Lancet 1958;2:483-8
   PubMed Web of Science ®Google Scholar
• Hood WE Jr, Bond WL. Iron deficiency prophylaxis during pregnancy. Obstet Gynecol 1960;16:82-4
   PubMed Web of Science ®Google Scholar
• Kirchhoff HW. Verträgliches Eisen in Depotform. Ergebnisse einer kontrollierten Vergleichsstudie. Arztl Prax 1978;30:1742-4
   Google Scholar
• Levy F, Andersen P, Ekren T. Absorption and side-effects after peroral administration of sustained release tablets. Acta Med Scand 1978;204:303-10
   PubMed Web of Science ®Google Scholar
• Leslie J. A comparative trial of a new controlled-release iron tablet (Ferrocontin) and a slow-release ferrous sulphate preparation (Feospan Spansule capsules). Clinical Trials J 1979;16:2-4
   Google Scholar
• Sas G, Nemesanszky E, Bräuer H, et al. On the therapeutic effects of trivalent and divalent iron in iron deficiency anaemia. Arzneimittelforschung 1984;34:1575-9
   PubMed Web of Science ®Google Scholar
• Brock C, Curry H, Hanna C, et al. Adverse effects of iron supplementation: a comparative trial of a wax-matrix iron preparation and conventional ferrous sulfate tablets. Clin Ther 1985;7:568-73
   PubMed Web of Science ®Google Scholar
• Gordeuk VR, Brittenham GM, Hughes M, et al. High-dose carbonyl iron for iron deficiency anemia: a randomized double-blind trial. Am J Clin Nutr 1987;46:1029-34
   PubMed Web of Science ®Google Scholar
• Coplin M, Schuette S, Leichtmann G, et al. Tolerability of iron: a comparison of bis-glycino iron II and ferrous sulfate. Clin Ther 1991;13:606-12
   PubMed Web of Science ®Google Scholar
• Devasthali SD, Gordeuk VR, Brittenham GM, et al. Bioavailability of carbonyl iron: a randomized, double-blind study. Eur J Haematol 1991;46:272-8
   PubMed Web of Science ®Google Scholar
• Liguori L. Iron protein succinylate in the treatment of iron deficiency: controlled, double-blind, multicenter clinical trial on over 1000 patients. Int J Clin Pharmacol Ther Toxicol 1993;31:105-23
   Google Scholar
• Al-Momen AK, al-Meshari A, al-Nuaim L, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol 1996;69:121-4
   PubMed Web of Science ®Google Scholar
• Bruner AB, Joffe A, Duggan AK, et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996;348:992-6
   PubMed Web of Science ®Google Scholar
• Casparis D, Del Carlo P, Branconi F, et al. Efficacia e tollerabilità del gluconato ferroso orale liquido nell’anemia da carenza da ferro in gravidanza e nell’immediato post-partum: confronto con altre formulazioni liquide o solide contenenti ferro bivalente o trivalente. Minerva Ginecol 1996;48:511-18
   PubMedGoogle Scholar
• Ekström EC, Kavishe FP, Habicht JP, et al. Adherence to iron supplementation during pregnancy in Tanzania: determinants and hematologic consequences. Am J Clin Nutr 1996;64:368-74
   PubMed Web of Science ®Google Scholar
• Surico G, Ciruzzi F, Miniello VL, et al. Curva da carico orale di ferro: confronto fra due preparati, ferro solfato e ferro gluconato. Riv Ital Pediatr 1998;24:1124-6
   Google Scholar
• Jacobs P, Wood L, Bird AR. Erythrocytes: better tolerance of iron polymaltose complex compared with ferrous sulphate in the treatment of anaemia. Hematology 2000;5:77-83
   PubMedGoogle Scholar
• Pujol Farriols R, Anglada Oriol M, Formiga Perez F, et al. Hierro protein-succinilato para el tratamiento de la anemia ferropénica del adulto. An Med Interna 2002;19:651-2
   PubMedGoogle Scholar
• Ahmed P, Mahmood A, Aziz S, et al. Comparison of response between food supplemented with powdered iron and iron in syrup form for iron deficiency anemia. J Coll Physicians Surg Pak 2003;13:402-4
   PubMedGoogle Scholar
• Makrides M, Crowther CA, Gibson RA, et al. Efficacy and tolerability of low-dose iron supplements during pregnancy: a randomized controlled trial. Am J Clin Nutr 2003;78:145-53
   PubMed Web of Science ®Google Scholar
• de Silva AD, Tsironi E, Feakins RM, et al. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. Aliment Pharmacol Ther 2005;22:1097-105
   PubMed Web of Science ®Google Scholar
• Van Wyck DB, Roppolo M, Martinez CO, et al. A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 2005;68:2846-56
   PubMed Web of Science ®Google Scholar
• Agarwal R, Rizkala AR, Bastani B, et al. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease. Am J Nephrol 2006;26:445-54
   PubMed Web of Science ®Google Scholar
• Bhandal N, Russell R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG 2006;113:1248-52
   PubMed Web of Science ®Google Scholar
• Christofides A, Asante KP, Schauer C, et al. Multi-micronutrient Sprinkles including a low dose of iron provided as microencapsulated ferrous fumarate improves haematologic indices in anaemic children: a randomized clinical trial. Matern Child Nutr 2006;2:169-80
   PubMed Web of Science ®Google Scholar
• Van Wyck DB, Martens MG, Seid MH, et al. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007;110:267-78
   PubMed Web of Science ®Google Scholar
• Melamed N, Ben-Haroush A, Kaplan B, et al. Iron supplementation in pregnancy--does the preparation matter? Arch Gynecol Obstet 2007;276:601-4
   PubMedGoogle Scholar
• Muneyyirci-Delale O, Richard-Davis G, Morris T, et al. Goserelin acetate 10.8 mg plus iron versus iron monotherapy prior to surgery in premenopausal women with iron-deficiency anemia due to uterine leiomyomas: results from a Phase III, randomized, multicenter, double-blind, controlled trial. Clin Ther 2007;29:1682-91
   PubMed Web of Science ®Google Scholar
• Breymann C, Gliga F, Bejenariu C, et al. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 2008;101:67-73
   PubMed Web of Science ®Google Scholar
• Westad S, Backe B, Salvesen KA, et al. A 12-week randomised study comparing intravenous iron sucrose versus oral ferrous sulphate for treatment of postpartum anemia. Acta Obstet Gynecol Scand 2008;87:916-23
   PubMed Web of Science ®Google Scholar
• Siegenthaler R. Klinische Prüfung des Eisenpräparates FS I69 (Tardyferon®). Basel: Dokumentationsdossier Robapharm AG, 1972
   Google Scholar
• Largiadèr A. Essai clinique des dragées retard Tardyferon. Schweiz Rundsch Med Prax 1973;62:578-82
   PubMedGoogle Scholar
• Kozlowska F. Behandlung der Eisenmangelanämien mit Tardyferon. Schweiz Rundsch Med Prax 1974;63:1092-7
   PubMedGoogle Scholar
• Holowiecki J, Stella-Holowiecka B, Harbut-Grylka A. Tardyferon-depot w leczeniu niedokrwistosci z neidoboru zelaza. Acta Haematol Pol 1976;7: 321-5
   PubMedGoogle Scholar
• Schusselé A, Petite J, Guinard D. Behandlung der Eisenmangelanämie mit Tardyferon. Schweiz Rundschau Med Prax 1976;65:245-51
   PubMedGoogle Scholar
• Díaz-Rubio García M, Díaz-Rubio García E. Ensayo clínico con el producto FS169 en las anemias sideropenicas. Med Clin (Barc) 1976;66:246-7
   Google Scholar
• Draganski K. Klinische Beurteilung von Tardyferon, einem Eisendepotpräparat. Wien Med Wochenschr 1977;127:714-17
   PubMedGoogle Scholar
• Hauser GA. Carence en fer et en acide folique durant la grossesse. Schweiz Rundsch Med Prax 1977;35:1127-31
   Google Scholar
• Thomann F. Fortschittliche orale Eisentherapie. Therapiewoche 1977;27:5315-23
   Google Scholar
• Germann M, Ginsheim-Gustavsburg. Problemloseorale eisen-langzeittherapie. Med Welt 1978;29:1904-5
   PubMedGoogle Scholar
• Müldner H. Oral Eisentherapie: ein neues erfolgreiches Konzept. Z Allg Med 1978;54: 545-53
   Google Scholar
• Popko J, Slowikowska J, Bogdanikowa B. The treatment of hypochromic anaemias with an iron depot preparation. Ars Medici 1978;11:519-20
   Google Scholar
• Steger W. Neue Aspekte oraler Eisensubstitution. Therapiewoche 1978;28:9156-62
   Google Scholar
• Hellerer O, Brückner WL, Beitz T, et al. Eisenresorption nach Gastrektomie unter Tardyferon-Medikation. Med Klin 1978;73:1543-8
   PubMedGoogle Scholar
• Oehlert G, Bandar A. Iron deficiency and oral substitution. Arztl Prax 1978;30:26-7
   Google Scholar
• Müldner H, Steger W. Ergebnisse einer Tardyferon – Doppelblindstudie. Therapiewoche 1979;29:3014-21
   Google Scholar
• Gerlach E. Effektvolle eisentherapie mit neuem konzept. Z Allg Med 1979;55:255-8
   Google Scholar
• Gaultier M. Une nouvelle thérapeutique des anémies hypochromes. Gaz Med Fr 1979;86:61-63
   Google Scholar
• Junck GU. A reliable method of iron and folic acid substitution during pregnancy. Therapiewoche 1980;30:7188-93
   Google Scholar
• Buzi E, Siegenthaler P. Substitution de fer chez les donneurs de sang. Etudes portant sur deux préparations de fer différentes au point de vue galénique. Schweiz Rundsch Med Prax 1980;47:1744-7
   Google Scholar
• Bernát IS, Konc J, Hollán Z. A Tardyferon terápiás hatékonysága és a mellékhatások elöfordulási gyakorisága. Gyógyszereink 1984;34:239-43
   Google Scholar
• Ifrah N, Houssin A, Girault P, et al. Apport de fer oral au cours des hémodialyses chroniques. Gazette Méd 1986;93:72-4
   Google Scholar
• Pengloan J, Abaza M. Effet de l’apport martial en prise unique chez l’hémodialysé chronique. Revue Méd Tours 1986;20:344-6
   Google Scholar
• Pejtsik B. Eisenmangei bei schwangeren und nichtschwangeren Frauen. In: Kaltwasser JP, Roetz R, eds. Eisenstoffwechsel-Grundlagen und Probleme, eds. Frankfurt: pmi Verlag, 1987
   Google Scholar
• Bernard W, Geier FP. Efficacy and safety of a slow-release ferrous sulphate preparation in geriatric patients with iron deficiency anaemia. Z Geriatrie 1989;2:1-11
   Google Scholar
• Mára M, Zivny J, Eretova V, et al. Changes in markers of anemia and iron metabolism and how they are influenced by antianemics in postpartum period. Acta Obstet Gynecol Scand 2001;80:142-8
   PubMed Web of Science ®Google Scholar
• Krafft A, Perewusnyk G, Hanseler E, et al. Effect of postpartum iron supplementation on red cell and iron parameters in non-anaemic iron-deficient women: a randomised placebo-controlled study. BJOG 2005;112:445-50
   PubMed Web of Science ®Google Scholar
• Konofal E, Lecendreux M, Deron J, et al. Effects of iron supplementation on attention deficit hyperactivity disorder in children. Pediatr Neurol 2008;38:20-6
   PubMed Web of Science ®Google Scholar
• De Renzo A, Buffardi S, Frigeri F, et al. Studio di efficacia e tollerabilità del ferroproteinsuccinilato verso ferritina nell’anemia sideropenica. Recenti Prog Med 1987;78:562-5
   PubMedGoogle Scholar
• Scremin S, Caprioglio L. Studio di efficacia e tollerabilità del ferro proteinsuccinilato nella carenza marziale. Boll Chim Farm 1988;127:44-9S
   Google Scholar
• Sallusto A, Eandi M, De Bartolo G, et al. [Ferroprotein succinylate: treatment of iron deficiency in obstetrics and gynecology]. Minerva Ginecol 1990;42:191-5
   PubMedGoogle Scholar
• Careddu P, Scotti A. Controlled, double-blind, multicenter clinical trial of iron protein succinylate in the treatment of iron deficiency in children. Int J Clin Pharmacol Ther Toxicol 1993;31:157-69
   PubMedGoogle Scholar
• Haliotis FA, Papanastasiou DA. Comparative study of tolerability and efficacy of iron protein succinylate versus iron hydroxide polymaltose complex in the treatment of iron deficiency in children. Int J Clin Pharmacol Ther 1998;36:320-5
   PubMed Web of Science ®Google Scholar
• Juarez-Vazquez J, Bonizzoni E, Scotti A. Iron plus folate is more effective than iron alone in the treatment of iron deficiency anaemia in pregnancy: a randomised, double blind clinical trial. BJOG 2002;109:1009-14
   PubMed Web of Science ®Google Scholar
• Black GS. A comparison of two iron tablet preparations in the treatment of iron deficiency anemia. J Int Med Res 1981;9:295
   PubMed Web of Science ®Google Scholar
• Adsul BB, Desai A, Gawde A, et al. Comparative assessment of the bioavailability, efficacy and safety of a modified-release (MR) carbonyl iron tablet and oral conventional iron preparation in adult Indian patients with nutritional iron deficiency anaemia. J Indian Med Assoc 2005;103:338-42
   PubMedGoogle Scholar
• Liu TC, Lin SF, Chang CS, et al. Comparison of a combination ferrous fumarate product and a polysaccharide iron complex as oral treatments of iron deficiency anemia: a Taiwanese study. Int J Hematol 2004;80:416-20
   PubMed Web of Science ®Google Scholar
• Kavakli K, Yilmaz D, Cetinkaya B, et al. Safety profiles of Fe2+ and Fe3+ oral preparations in the treatment of iron deficiency anemia in children. Pediatr Hematol Oncol 2004;21:403-10
   PubMed Web of Science ®Google Scholar
• Radtke H, Mayer B, Rocker L, et al. Iron supplementation and 2-unit red blood cell apheresis: a randomized, double-blind, placebo-controlled study. Transfusion 2004;44:1463-7
   PubMed Web of Science ®Google Scholar
• Rimon E, Kagansky N, Kagansky M, et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005;118:1142-7
   PubMed Web of Science ®Google Scholar
• Wall CR, Grant CC, Taua N, et al. Milk versus medicine for the treatment of iron deficiency anaemia in hospitalised infants. Arch Dis Child 2005;90:1033-8
   PubMed Web of Science ®Google Scholar
• Horváth K, Horn G. Tardyferon therapy in hyposiderosis of infancy and childhood. Ther Hung 1992;40:40-3
   PubMedGoogle Scholar
• Fadeenko GD, Kushnir IE. Tardyferon in the treatment of iron deficiency anaemia: clinical efficacy and safety. Suchasna Gastroenterologia 2009;5:74-80
   Google Scholar
• Nielsen P, Kongi R, Fischer R. Efficacy of a prolonged-release iron preparation in iron deficiency. Abstract ID 433. 16th WONCA Europe Conference. Málaga, Spain. 6-9 October 2010
   Google Scholar
• Kim YK, Park SM, Kim CS. Effect of mucoproteose on aspirin induced gastric mucosal lesions in rats. Korean J Gastroenterol 1984;16:33-4
   Google Scholar
• Lacerte P, Pradipasen M, Temcharoen P, et al. Determinants of adherence to iron/folate supplementation during pregnancy in two provinces in Cambodia. Asia Pac J Public Health 2011;23:315-23
   PubMed Web of Science ®Google Scholar
• Viteri FE. Iron supplementation for the control of iron deficiency in populations at risk. Nutr Rev 1997;55:195-209
   PubMed Web of Science ®Google Scholar
• Bilenko N, Yehiel M, Inbar Y, et al. The association between anemia in infants, and maternal knowledge and adherence to iron supplementation in southern Israel. Isr Med Assoc J 2007;9:521-4
   PubMed Web of Science ®Google Scholar
• Lachance K, Savoie M, Bernard M, et al. Oral ferrous sulfate does not increase preoperative hemoglobin in patients scheduled for hip or knee arthroplasty. Ann Pharmacother 2011;45:764-70
   PubMed Web of Science ®Google Scholar
• Donnez J, Tatarchuk TF, Bouchard P, et al. Ulipristal acetate versus placebo for fibroid treatment before surgery. N Engl J Med 2012;366:409-20
   PubMed Web of Science ®Google Scholar